Skip to Content

'
Bouthaina S. Dabaja, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1990 Lebanese University-Faculty of Medicine, Beirut, Lebanon, MD, Medicine

Postgraduate Training

2003-2006 Assistant Professor, Radiation Oncology and Medical Oncology, American University of Beirut-Faculty of Medicine, Beirut, Lebanon
2003 Clinical Fellowship, Stereotactic 3D Conformal Fellowship, The University of Texas M.D. Anderson Cancer Center (Non-Accredited Participation in Program), Houston, TX
1999-2003 Clinical Residency, Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
1997-1999 Clinical Fellowship, Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
1993-1996 Clinical Fellowship, Hematology, American University of Beirut-Faculty of Medicine, Beirut, Lebanon
1990-1993 Clinical Residency, Internal Medicine, American University of Beirut-Faculty of Medicine, Beirut, Lebanon

Board Certifications

6/2003 American Board of Radiation Oncology

Honors and Awards

2003 Janice Davis Singletary
2003 Nominated to the Oncology Fellows Connect Program
2002 Honorary Merit-Radiation Research Award
2001 Research Education Award, The University of Texas M.D. Anderson Cancer Center

Selected Publications

Peer-Reviewed Original Research Articles
1. Geara F, Nasr E, Tucker SL, Chrafeddine M, Dabaja B, EId T, Abbas J, Salem Z, Shamseddine A, Issa P, and El Saghir N. Breast Cancer Patients with 10 or More Axillary Lymph Nodes Involvement Treated by Multimodality Therapy: Influennce of Clinical Presentaion on Outcome. Int J Radiat Oncol Biol Phys 68(2):364-9, 6/2007.
2. Dabaja B, Cox JD, Buchholz TA. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma. J Clin Oncol 25(1):3-5, 2007.
3. Dabaja BS, Salehpour MR, Rosen I, Tung S, Morrison WH, Ang KK, Garden AS. Intensity modulated radiation therapy (IMRT) of cancers of the head and neck: comparision of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 63:1000-1005, 2005.
4. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcomes of 217 patients. Cancer 101:518-526, 2004.
5. Dabaja BS, Ha CS, Wilder RB, Pro B, McLaughlin P, Cabanillas F, Cox JD. Importance of esophagogastroduodenscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer J 9:321-324, 2003.
6. Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Cancer 98:1021-1028, 2003.
7. Cox JD, Ha CS, Lee HK, Dabaja BS, Wilder RB. Uncertainities in contemporary treatment of aggressive lymphomas. Rays 28:289-292, 2003.
8. Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 94:2738-2744, 2002.
9. Dabaja BS, O'Brien SM, Kantarjian HM, Cortes JE, Thomas DA, Albitar M, Schlette ES, Faderl S, Sarris A, Keating MJ, Giles FJ. Fractionated cyclophosphamide, vincristine, liposmal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma 42(3):329-337, 2001.
10. Taher A, Ammash Z, Dabaja B, Nasrallah A, Mourad FH. Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: Case report and literature review. Am J Hematol 63(2):90-93, 2000.
11. Taher A, Shamsseddine A, Saghir N, Seoud M, Mourad F, Dabaja B, Khalil A. Acquired protein C deficiency following cisplatinum-navalbine administration for locally advanced breast cancer. Eur J Gyneacol Oncol 20(4):323-324, 1999.
12. Shameseddine A, Taher A, Dabaja B, Dandashi A, Salem Z, El Saghir NS. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer. Am J Clin Oncol 22(3):298-302, 1999.
13. Dabaja BS, Faderl S, Thomas D, Cortes J, O'Brien S, Nasr F, Pierce S, Hayes K, Glassman A, Keating M, Kantarjian HM. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic: incidence, associations and implications. Leukemia 13(6):869-872, 1999.

Last updated: 9/23/2009